Structure Therapeutics is trading 4.86% lower at $31.10 on September 30, 2026, with no clear catalyst identified. - This marks a second consecutive session of losses, following a 6.77% decline on September 29. - Available coverage has not verified a company-specific announcement or established the cause of the move. - The broader market is mixed, with the Nasdaq higher; the supplied market context does not clearly explain the stock’s decline.